Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2021
Total Assets: $181.48B
Liabilities Breakdown FY2021
Total Liabilities: $104.01B
Asset Breakdown
Total Assets: $181.48B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.94B | 1.1% |
| Accounts Receivable | $11.48B | 6.3% |
| Inventory | $9.06B | 5.0% |
| Property, Plant & Equipment | $14.88B | 8.2% |
| Goodwill | $49.21B | 27.1% |
| Intangible Assets | $25.15B | 13.9% |
| Other Assets | $69.76B | 38.4% |
Liabilities Breakdown
Total Liabilities: $104.01B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.58B | 5.4% |
| Long-Term Debt | $36.20B | 34.8% |
| Other Liabilities | $62.24B | 59.8% |